Healthcare provider profile · identity verified

Davina Dansby, MD

Family Practice · STONE MOUNTAIN, GA · NPI 1265553176

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	348	117
Amlodipine Besylate	Amlodipine Besylate	290	89
Levothyroxine Sodium	Levothyroxine Sodium	184	54
Losartan Potassium	Losartan Potassium	152	48
Albuterol Sulfate Hfa	Albuterol Sulfate	111	42
Hydrochlorothiazide	Hydrochlorothiazide	111	37
Lisinopril	Lisinopril	107	32
Tramadol Hcl	Tramadol Hcl	107	17
Metoprolol Succinate	Metoprolol Succinate	99	31
Pantoprazole Sodium	Pantoprazole Sodium	98	28
Gabapentin	Gabapentin	93	32
Metformin Hcl	Metformin Hcl	91	31
Clonazepam	Clonazepam	90	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	14
Ozempic	Semaglutide	87	18
Rosuvastatin Calcium	Rosuvastatin Calcium	86	29
Alendronate Sodium	Alendronate Sodium	80	27
Tizanidine Hcl	Tizanidine Hcl	74	31
Potassium Chloride	Potassium Chloride	73	25
Famotidine	Famotidine	72	25
Metoprolol Tartrate	Metoprolol Tartrate	71	17
Pravastatin Sodium	Pravastatin Sodium	69	21
Fluticasone Propionate	Fluticasone Propionate	60	24
Omeprazole	Omeprazole	59	26
Simvastatin	Simvastatin	59	18
Carvedilol	Carvedilol	58	20
Metformin Hcl Er	Metformin Hcl	58	19
Diclofenac Sodium	Diclofenac Sodium	54	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	16
Montelukast Sodium	Montelukast Sodium	53	19
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	16
Trazodone Hcl	Trazodone Hcl	52	25
Furosemide	Furosemide	51	15
Olmesartan Medoxomil	Olmesartan Medoxomil	51	14
Allopurinol	Allopurinol	50	15
Irbesartan	Irbesartan	50	13
Meloxicam	Meloxicam	50	19
Spironolactone	Spironolactone	50	14
Escitalopram Oxalate	Escitalopram Oxalate	48	15
Buspirone Hcl	Buspirone Hcl	43	suppressed
Hydralazine Hcl	Hydralazine Hcl	42	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	14
Lovastatin	Lovastatin	41	16
Ezetimibe	Ezetimibe	40	12
Alprazolam	Alprazolam	39	suppressed
Meclizine Hcl	Meclizine Hcl	39	13
Glimepiride	Glimepiride	38	11
Mounjaro	Tirzepatide	38	suppressed
Duloxetine Hcl	Duloxetine Hcl	37	13
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Pregabalin	Pregabalin	35	suppressed
Eliquis	Apixaban	34	12
Prednisone	Prednisone	34	28
Candesartan Cilexetil	Candesartan Cilexetil	33	11
Ibandronate Sodium	Ibandronate Sodium	30	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Diazepam	Diazepam	27	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	27	suppressed
Jardiance	Empagliflozin	25	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Nystatin	Nystatin	24	suppressed
Promethazine Hcl	Promethazine Hcl	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Myrbetriq	Mirabegron	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Torsemide	Torsemide	23	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	22	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Bupropion Xl	Bupropion Hcl	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	12
Candesartan-Hydrochlorothiazid	Candesartan/Hydrochlorothiazid	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Atenolol	Atenolol	19	suppressed
Gemtesa	Vibegron	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Linzess	Linaclotide	17	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Ibuprofen	Ibuprofen	16	11
Klor-Con M20	Potassium Chloride	16	suppressed
Mometasone Furoate	Mometasone Furoate	16	suppressed
Naproxen	Naproxen	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Synthroid	Levothyroxine Sodium	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	15	suppressed
Finasteride	Finasteride	15	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	15	suppressed
Humira(Cf) Pen	Adalimumab	15	suppressed
Colchicine	Colchicine	14	suppressed
Epinephrine	Epinephrine	14	11
Janumet	Sitagliptin Phos/Metformin Hcl	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Topiramate	Topiramate	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Estradiol	Estradiol	12	suppressed
Valsartan	Valsartan	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Acyclovir	Acyclovir	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error